Dr Lal PathLabs Q1 results: Profit up 24% aided by higher sampling; interim dividend declared

Dr Lal PathLabs posted a 24% YoY rise in Q1 profit to ₹132 crore, driven by higher sample volumes. Revenue grew 11.3%, and the board declared an interim dividend.

Leave a Reply

Your email address will not be published. Required fields are marked *